vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and FUELCELL ENERGY INC (FCEL). Click either name above to swap in a different company.

FUELCELL ENERGY INC is the larger business by last-quarter revenue ($55.0M vs $39.8M, roughly 1.4× Carter Bankshares, Inc.). On growth, Carter Bankshares, Inc. posted the faster year-over-year revenue change (15.4% vs 11.5%). Carter Bankshares, Inc. produced more free cash flow last quarter ($31.8M vs $-23.9M). Over the past eight quarters, FUELCELL ENERGY INC's revenue compounded faster (81.6% CAGR vs 9.1%).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

FuelCell Energy, Inc. is a publicly traded fuel cell company headquartered in Danbury, Connecticut. It designs, manufactures, operates and services power plants based on molten carbonate fuel cells.

CARE vs FCEL — Head-to-Head

Bigger by revenue
FCEL
FCEL
1.4× larger
FCEL
$55.0M
$39.8M
CARE
Growing faster (revenue YoY)
CARE
CARE
+3.9% gap
CARE
15.4%
11.5%
FCEL
More free cash flow
CARE
CARE
$55.7M more FCF
CARE
$31.8M
$-23.9M
FCEL
Faster 2-yr revenue CAGR
FCEL
FCEL
Annualised
FCEL
81.6%
9.1%
CARE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CARE
CARE
FCEL
FCEL
Revenue
$39.8M
$55.0M
Net Profit
$-29.9M
Gross Margin
-12.1%
Operating Margin
27.8%
-51.5%
Net Margin
-54.3%
Revenue YoY
15.4%
11.5%
Net Profit YoY
27.9%
EPS (diluted)
$0.38
$-0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
FCEL
FCEL
Q4 25
$39.8M
$55.0M
Q3 25
$39.1M
$46.7M
Q2 25
$37.3M
$37.4M
Q1 25
$37.0M
$19.0M
Q4 24
$34.5M
$49.3M
Q3 24
$34.2M
$23.7M
Q2 24
$33.6M
$22.4M
Q1 24
$33.5M
$16.7M
Net Profit
CARE
CARE
FCEL
FCEL
Q4 25
$-29.9M
Q3 25
$5.4M
$-91.7M
Q2 25
$8.5M
$-38.0M
Q1 25
$9.0M
$-28.3M
Q4 24
$-41.4M
Q3 24
$5.6M
$-32.7M
Q2 24
$4.8M
$-32.1M
Q1 24
$5.8M
$-19.8M
Gross Margin
CARE
CARE
FCEL
FCEL
Q4 25
-12.1%
Q3 25
-11.0%
Q2 25
-25.2%
Q1 25
-27.4%
Q4 24
-22.1%
Q3 24
-26.2%
Q2 24
-31.6%
Q1 24
-70.2%
Operating Margin
CARE
CARE
FCEL
FCEL
Q4 25
27.8%
-51.5%
Q3 25
18.3%
-204.0%
Q2 25
28.5%
-95.7%
Q1 25
30.1%
-172.9%
Q4 24
31.0%
-83.2%
Q3 24
20.5%
-141.9%
Q2 24
17.6%
-184.5%
Q1 24
21.6%
-254.5%
Net Margin
CARE
CARE
FCEL
FCEL
Q4 25
-54.3%
Q3 25
13.9%
-196.1%
Q2 25
22.8%
-101.7%
Q1 25
24.2%
-149.1%
Q4 24
-84.0%
Q3 24
16.4%
-137.8%
Q2 24
14.3%
-143.4%
Q1 24
17.4%
-118.6%
EPS (diluted)
CARE
CARE
FCEL
FCEL
Q4 25
$0.38
$-0.43
Q3 25
$0.24
$-3.78
Q2 25
$0.37
$-1.79
Q1 25
$0.39
$-1.42
Q4 24
$0.36
$-2.29
Q3 24
$0.24
$-1.99
Q2 24
$0.21
$-2.18
Q1 24
$0.25
$-1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
FCEL
FCEL
Cash + ST InvestmentsLiquidity on hand
$278.1M
Total DebtLower is stronger
$103.8M
Stockholders' EquityBook value
$419.7M
$662.2M
Total Assets
$4.9B
$932.1M
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CARE
CARE
FCEL
FCEL
Q4 25
$278.1M
Q3 25
$174.7M
Q2 25
$177.0M
Q1 25
$208.4M
Q4 24
$257.3M
Q3 24
$267.2M
Q2 24
$260.1M
Q1 24
$297.5M
Total Debt
CARE
CARE
FCEL
FCEL
Q4 25
$103.8M
Q3 25
$106.4M
Q2 25
$109.4M
Q1 25
$112.3M
Q4 24
$115.7M
Q3 24
$112.7M
Q2 24
$116.2M
Q1 24
$107.2M
Stockholders' Equity
CARE
CARE
FCEL
FCEL
Q4 25
$419.7M
$662.2M
Q3 25
$412.8M
$556.2M
Q2 25
$405.6M
$609.2M
Q1 25
$401.8M
$635.2M
Q4 24
$384.3M
$656.9M
Q3 24
$386.8M
$675.8M
Q2 24
$364.4M
$639.8M
Q1 24
$359.1M
$663.9M
Total Assets
CARE
CARE
FCEL
FCEL
Q4 25
$4.9B
$932.1M
Q3 25
$4.8B
$830.5M
Q2 25
$4.8B
$883.8M
Q1 25
$4.7B
$907.5M
Q4 24
$4.7B
$944.1M
Q3 24
$4.6B
$948.9M
Q2 24
$4.5B
$916.8M
Q1 24
$4.6B
$923.2M
Debt / Equity
CARE
CARE
FCEL
FCEL
Q4 25
0.16×
Q3 25
0.19×
Q2 25
0.18×
Q1 25
0.18×
Q4 24
0.18×
Q3 24
0.17×
Q2 24
0.18×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
FCEL
FCEL
Operating Cash FlowLast quarter
$39.9M
$-22.9M
Free Cash FlowOCF − Capex
$31.8M
$-23.9M
FCF MarginFCF / Revenue
79.9%
-43.4%
Capex IntensityCapex / Revenue
20.2%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$54.6M
$-143.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
FCEL
FCEL
Q4 25
$39.9M
$-22.9M
Q3 25
$11.8M
$-26.8M
Q2 25
$9.6M
$-29.9M
Q1 25
$6.4M
$-45.7M
Q4 24
$36.9M
$5.8M
Q3 24
$10.3M
$-63.4M
Q2 24
$-2.5M
$-37.1M
Q1 24
$17.6M
$-58.3M
Free Cash Flow
CARE
CARE
FCEL
FCEL
Q4 25
$31.8M
$-23.9M
Q3 25
$10.3M
$-32.1M
Q2 25
$7.7M
$-35.2M
Q1 25
$4.9M
$-52.8M
Q4 24
$28.8M
$-4.7M
Q3 24
$8.4M
$-76.8M
Q2 24
$-4.3M
$-50.3M
Q1 24
$16.3M
$-68.8M
FCF Margin
CARE
CARE
FCEL
FCEL
Q4 25
79.9%
-43.4%
Q3 25
26.3%
-68.6%
Q2 25
20.6%
-94.0%
Q1 25
13.1%
-277.8%
Q4 24
83.5%
-9.5%
Q3 24
24.6%
-324.0%
Q2 24
-12.7%
-224.5%
Q1 24
48.8%
-412.4%
Capex Intensity
CARE
CARE
FCEL
FCEL
Q4 25
20.2%
1.8%
Q3 25
3.9%
11.2%
Q2 25
5.1%
14.1%
Q1 25
4.1%
37.2%
Q4 24
23.6%
21.4%
Q3 24
5.5%
56.6%
Q2 24
5.4%
58.9%
Q1 24
3.9%
63.3%
Cash Conversion
CARE
CARE
FCEL
FCEL
Q4 25
Q3 25
2.18×
Q2 25
1.13×
Q1 25
0.71×
Q4 24
Q3 24
1.83×
Q2 24
-0.51×
Q1 24
3.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CARE
CARE

Segment breakdown not available.

FCEL
FCEL

Other$30.0M55%
Electricity Generation$12.2M22%
Services$7.3M13%
Advanced Technologies$5.5M10%

Related Comparisons